Ansa Biotechnologies Raises $71.5M to Scale DNA Synthesis
Ansa Biotechnologies raised $71.5 million in an oversubscribed Series C led by Blue Water Life Science Advisors, lifting total funding to $211 million after quadrupling manufacturing capacity.
